Biodefense Market to surpass US$24.5 billion by 2030


Fairfield Market Research, a leading market research firm, has released a comprehensive report projecting substantial revenue growth in the UK biodefense market over the next decade. The report highlights key findings, growth drivers, and challenges in the industry, along with an overview of key segments and growth opportunities across regions.

According to the report, the global biodefense market registered revenue worth US$14.8 billion in 2022, and it is expected to witness a robust CAGR of 6.3% during the period of assessment. By 2030, the market size is projected to reach a valuation of US$24.5 billion. Anthrax is identified as the leading segment based on the type of biodefense products, while the military segment accounts for the largest share in the market by end use.

Access Full Report: https://www.fairfieldmarketresearch.com/report/biodefense-market

The report cites increasing prevalence of infectious diseases, mounting demand in the wake of potential bioterrorist attacks, growing geopolitical conflicts, and technological advances as key growth drivers for the biodefense market. Governments worldwide are expected to expand their budgets for research and development of biodefense treatments, leading to an exponential spike in demand for biodefense products in the next five years.

In terms of regional growth, North America, spearheaded by favorable federal funding, currently leads the biodefense market. However, the Asia Pacific region is predicted to showcase the fastest growth through 2030. Europe, with increased R&D expenditure during the COVID-19 pandemic, and mature markets like Australia and Japan, benefitting from well-established quality and safety norms, are also turning into lucrative markets.

The highly competitive market space has prompted leading players to adopt advanced technologies and strategic collaborations. Key companies operating in the global biodefense market include Emergent BioSolutions, Inc., SIGA Technologies, Inc., Bavarian Nordic A/S, Altimmune, Inc., GSK plc, Sanofi Pasteur, and others.

As the UK biodefense market emerges as a key player in the industry, new entrants are attracted by promising opportunities such as fostering partnerships, expanding manufacturing capabilities, and catalyzing innovation across the development pipeline for biodefense purposes.

Comments

Post a Comment

Popular posts from this blog

Australia Bicycle Market Size and Analysis 2021-2026

Image
The bicycle market in Australia is set to witness substantial growth in the coming years, driven by the increasing demand for green and sustainable transportation options. According to a recent report, the global bicycle market is projected to reach a value of US$100.8 billion by 2026, registering a remarkable compound annual growth rate (CAGR) of 12.7% between 2021 and 2026. The Australian bicycle market is expected to contribute significantly to this growth trend. Access Full Report: https://www.fairfieldmarketresearch.com/report/bicycle-market   One of the key drivers behind the surge in bicycle sales is the growing concern about environmental impact and the need for eco-friendly transportation alternatives. With mounting worries about carbon emissions and vehicular pollution, governments and consumers alike are embracing bicycling as a greener and healthier mode of transportation. The Australian government has also been undertaking various initiatives to reduce carbon emissi...
Read more

Global Narcolepsy Drugs Market Analysis, Share and Size 2021-2026

Image
The global narcolepsy drugs market is poised for robust revenue growth in the coming years, according to Fairfield Market Research. With increasing prevalence and awareness of narcolepsy, the market is expected to exhibit a healthy pace of 11.2% CAGR during the forecast period from 2021 to 2026, reaching a value of US$6588.0 million by 2026, compared to US$3875.1 million in 2021. Narcolepsy, a neurological condition affecting approximately one in every 2000 people in the U.S., poses significant challenges to patients' daily lives. Symptoms such as excessive daytime sleepiness, cataplexy, automatic behaviors, hallucinations, and sleep paralysis hinder normal functionality at work and in social situations. However, despite the debilitating nature of the condition, narcolepsy often goes undiagnosed, with misdiagnosis rates as high as 75%. Access Full Report: https://www.fairfieldmarketresearch.com/report/narcolepsy-drugs-market Early detection and diagnosis are crucial in providin...
Read more

From Niche to Mainstream: The Evolving Dynamics of the Foam Roller Market 2023-2030

Image
The global foam roller market, currently valued at 1.8 billion USD, is projected to experience substantial growth at a compounded annual growth rate (CAGR) of 8% in the coming years. This remarkable trajectory can be attributed primarily to the increasing demand for rehabilitation equipment, driven by the growing prevalence of back pain and tight muscles among individuals worldwide. Access Full Report: https://www.fairfieldmarketresearch.com/report/foam-roller-market The foam roller, a versatile tool used by athletes across all sports, has gained popularity for its ability to assist in stretching out muscles and relieving knots and myofascial build-up. Regular exercise often leads to strains and tightness, and foam rollers prove instrumental in aiding athletes' quick recovery from physical stress. Among the commonly sold foam roller types are hollow and solid foam rollers, both of which effectively loosen muscles and tendons. Runners, for instance, can utilize these equipment pi...
Read more